Allergy Asthma Immunol Res.  2020 May;12(3):378-380. 10.4168/aair.2020.12.3.378.

Active Pharmacovigilance of Drug-Induced Liver Injury Using Electronic Health Records

• Kim SH

• KMID: 2471223
• DOI: http://doi.org/10.4168/aair.2020.12.3.378

Abstract

No abstract available.

MeSH Terms

Drug-Induced Liver Injury*
Electronic Health Records*
Pharmacovigilance*

Reference

1. Kim SH, Naisbitt DJ. Update on advances in research on idiosyncratic drug-induced liver injury. Allergy Asthma Immunol Res. 2016; 8:3–11.

2. Harpaz R, DuMouchel W, Shah NH, Madigan D, Ryan P, Friedman C. Novel data-mining methodologies for adverse drug event discovery and analysis. Clin Pharmacol Ther. 2012; 91:1010–1021.

3. Tan EH, Low EX, Dan YY, Tai BC. Systematic review and meta-analysis of algorithms used to identify drug-induced liver injury (DILI) in health record databases. Liver Int. 2018; 38:742–753.

4. Pérez Gutthann S, García Rodríguez LA. The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs. Epidemiology. 1993; 4:496–501.

5. Kang Y, Kim SH, Park SY, Park BY, Lee JH, An J, et al. Evaluation of drug-induced liver injury developed during hospitalization using electronic health record (EHR)-based algorithm. Allergy Asthma Immunol Res. 2020; 12:430–442.

6. Bui CL, Kaye JA, Castellsague J, Calingaert B, McQuay LJ, Riera-Guardia N, et al. Validation of acute liver injury cases in a population-based cohort study of oral antimicrobial users. Curr Drug Saf. 2014; 9:23–28.

7. Shin J, Hunt CM, Suzuki A, Papay JI, Beach KJ, Cheetham TC. Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data. Pharmacoepidemiol Drug Saf. 2013; 22:190–198.

8. Udo R, Maitland-van der Zee AH, Egberts TC, den Breeijen JH, Leufkens HG, van Solinge WW, et al. Validity of diagnostic codes and laboratory measurements to identify patients with idiopathic acute liver injury in a hospital database. Pharmacoepidemiol Drug Saf. 2016; 25 Suppl 1:21–28.

9. Meier Y, Cavallaro M, Roos M, Pauli-Magnus C, Folkers G, Meier PJ, et al. Incidence of drug-induced liver injury in medical inpatients. Eur J Clin Pharmacol. 2005; 61:135–143.

10. Heidemann L, Law J, Fontana RJ. A text searching tool to identify patients with idiosyncratic drug-induced liver injury. Dig Dis Sci. 2017; 62:615–625.

11. Liu M, McPeek Hinz ER, Matheny ME, Denny JC, Schildcrout JS, Miller RA, et al. Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records. J Am Med Inform Assoc. 2013; 20:420–426.

12. Cheetham TC, Lee J, Hunt CM, Niu F, Reisinger S, Murray R, et al. An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data. Pharmacoepidemiol Drug Saf. 2014; 23:601–608.

13. Ferrajolo C, Coloma PM, Verhamme KM, Schuemie MJ, de Bie S, Gini R, et al. Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network. Drug Saf. 2014; 37:99–108.

14. Kim SH, Kim SH, Lee JH, Lee BH, Yoon HJ, Shin DH, et al. Superoxide dismutase gene (SOD1, SOD2, and SOD3) polymorphisms and antituberculosis drug-induced hepatitis. Allergy Asthma Immunol Res. 2015; 7:88–91.

15. Choi YH, Han CY, Kim KS, Kim SG. Future directions of pharmacovigilance studies using electronic medical recording and human genetic databases. Toxicol Res. 2019; 35:319–330.